These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6395923)
1. [Hemostasis and tumor invasion. Therapeutic implications]. Cattan A Bull Cancer; 1984; 71(5):481-93. PubMed ID: 6395923 [TBL] [Abstract][Full Text] [Related]
2. The role of hemostasis and fibrinolysis in the metastatic spread of cancer. Markus G Semin Thromb Hemost; 1984 Jan; 10(1):61-70. PubMed ID: 6538342 [No Abstract] [Full Text] [Related]
4. Antimetastatic agents. II. Summary of the interactions of tumor cells with blood coagulation factors, platelets, fibrinolytic factors, and inflammatory cells and their soluble mediators: potential for therapeutic interventions. Rickles FR; Hancock WW Semin Thromb Hemost; 1988 Jan; 14(1):126-32. PubMed ID: 3353730 [TBL] [Abstract][Full Text] [Related]
5. Antitumor and antimetastatic effect of warfarin and heparins. Bobek V; Kovarík J Biomed Pharmacother; 2004 May; 58(4):213-9. PubMed ID: 15183845 [TBL] [Abstract][Full Text] [Related]
6. Clinical studies with anticoagulants to improve survival in cancer patients. Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993 [TBL] [Abstract][Full Text] [Related]
7. Recent progress in fibrinolysis. Mannucci PM; Minetti D; Mari D Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):328-35. PubMed ID: 160079 [No Abstract] [Full Text] [Related]
9. [Coagulo-fibrinolytic system and platelets in cancer--clinical and experimental study on the influence of coagulo-fibrinolytic system and platelets on tumor growth and metastasis]. Ojiro M Igaku Kenkyu; 1983 Mar; 53(2):63-99. PubMed ID: 6375232 [No Abstract] [Full Text] [Related]
10. [The role of proteases in the growth, invasion and spread of cancer cells]. Buø L; Aasen AO; Karlsrud TS; Johansen HT; Sivertsen SM Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3753-6. PubMed ID: 2274946 [TBL] [Abstract][Full Text] [Related]
11. Heparin in tumor progression and metastatic dissemination. Falanga A; Marchetti M Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796 [TBL] [Abstract][Full Text] [Related]
12. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma. Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650 [TBL] [Abstract][Full Text] [Related]
13. Protein C and its inhibitor in malignancy. Suzuki K; Hayashi T Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793 [TBL] [Abstract][Full Text] [Related]
14. Cell interactions in the metastatic process: some cell surface properties associated with successful blood-borne tumor spread. Nicolson GL; Birdwell CR; Brunson KW; Robbins JC; Beattie G; Fidler IJ Soc Gen Physiol Ser; 1977; 32():225-41. PubMed ID: 333594 [No Abstract] [Full Text] [Related]
15. [Cancer, hemostasis and coaguloactive drugs]. Nadiradze ISh Vopr Onkol; 1989; 35(12):1411-8. PubMed ID: 2692281 [No Abstract] [Full Text] [Related]
16. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation. Amirkhosravi M; Francis JL Thromb Haemost; 1995 Jan; 73(1):59-65. PubMed ID: 7740497 [TBL] [Abstract][Full Text] [Related]
17. The effect of heparin and warfarin on primary and metastatic tumors. Millar RC; Ketcham AS J Med; 1974; 5(1):23-31. PubMed ID: 4598770 [No Abstract] [Full Text] [Related]
18. Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance. Vlodavsky I; Schirrmacher V; Ariav Y; Fuks Z Invasion Metastasis; 1983; 3(2):81-97. PubMed ID: 6677623 [TBL] [Abstract][Full Text] [Related]